Legend Strategy Completes Auro Hong Kong Acquisition, Gains Beisheng Stake

MT Newswires Live

Mar 06

Legend Strategy International (HKG:1355) said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.

The deal stems from a sale and purchase agreement signed in December 2025, under which Legend Strategy agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.

Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.

Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2617685785"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2617685785\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2617685785?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 17:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2617685785","market":"sh","top_or_hot":-1,"title":"Legend Strategy Completes Auro Hong Kong Acquisition, Gains Beisheng Stake","media":"MT Newswires Live","content":"<html><body><p> Legend <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> International (HKG:1355) said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.</p><p>The deal stems from a sale and purchase agreement signed in December 2025, under which Legend <a href=\"https://laohu8.com/S/STRF\">Strategy</a> agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.</p><p>Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.</p><p>Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Legend Strategy Completes Auro Hong Kong Acquisition, Gains Beisheng Stake</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLegend Strategy Completes Auro Hong Kong Acquisition, Gains Beisheng Stake\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-06 17:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Legend <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> International (HKG:1355) said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.</p><p>The deal stems from a sale and purchase agreement signed in December 2025, under which Legend <a href=\"https://laohu8.com/S/STRF\">Strategy</a> agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.</p><p>Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.</p><p>Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MST","symbol_name":"做多杠杆+收益MSTR ETF-Defiance","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2617685785","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2617685785","pubTimestamp":1772788507,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Legend Strategy International  said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.The deal stems from a sale and purchase agreement signed in December 2025, under which Legend Strategy agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MST":"做多杠杆+收益MSTR ETF-Defiance","BK4595":"比特币概念","09799":"南方两倍做多MSTR-U","MSTY.UK":"YIELDMAX MSTR OPTION INCOME STRATEGY ETC","SMI3.UK":"GRANITESHARES 3X SHORT MSTR DAILY ETP","BK4023":"应用软件","07799":"南方两倍做多MSTR","BK1164":"酒店、度假村与豪华游轮","MSII":"REX MSTR Growth & Income ETF","3LMI.UK":"GRANITESHARES 3X LONG MSTR DAILY ETP","MSTK":"Tuttle Capital MSTR 0DTE Covered Call ETF","MSDD":"2倍做空MSTR ETF-GraniteShares","09399":"南方两倍做空MSTR-U","MSTP":"2倍做多MSTR ETF-GraniteShares","LMI3.UK":"GRANITESHARES 3X LONG MSTR DAILY ETP","BK4585":"ETF&股票定投概念","07399":"南方两倍做空MSTR","01355":"朸浚国际","MSOO":"2倍上限加速MSTR ETF-Leverage Shares","APED":"STKd 100% MSTR & 100% COIN ETF","SMST":"2倍做空MSTR ETF-Defiance","MTYY":"GraniteShares YieldBOOST MSTR ETF","BK4516":"特朗普概念","MSTW":"Roundhill MSTR WeeklyPay ETF","BK4596":"哈里斯概念","MSTX":"2倍做多MSTR ETF-Defiance","BK4588":"碎股","WNTR":"做空MSTR期权收益策略ETF-YieldMax","MSTY":"MSTR期权收益策略ETF-YieldMax","BK4600":"加密货币概念","IMST":"MSTR期权收益策略ETF-Bitwise","MSST":"YieldMax MSTR Performance & Distribution Target 25 ETF","MSTZ":"2倍做空MSTR ETF-T-Rex","3SMI.UK":"GRANITESHARES 3X SHORT MSTR DAILY ETP"},"translate_title":"联想战略完成奥诺香港收购，获得北盛股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APED":0.6,"SMI3.UK":0.6,"MSTZ":0.6,"MSTK":0.6,"WNTR":0.6,"MSDD":0.6,"07799":0.6,"09399":0.6,"IMST":0.6,"MST":0.6,"MSST":0.6,"07399":0.6,"MSTP":0.6,"LMI3.UK":0.6,"01355":1.96,"MSTY.UK":0.6,"MSTY":0.6,"MTYY":0.6,"3LMI.UK":0.6,"SMST":0.6,"09799":0.6,"MSTW":0.6,"3SMI.UK":0.6,"MSOO":0.6,"MSTX":0.6,"MSII":0.6},"content_text":"Legend Strategy International (HKG:1355) said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.The deal stems from a sale and purchase agreement signed in December 2025, under which Legend Strategy agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}